Inventor
TSUI PING
US24 patents
⚠️ This page may combine multiple inventors who share the name “TSUI PING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SMITHKLINE BEECHAM CORP
9 patentsUS6130067AOct 10, 2000
Human EDG3sb gene
SMITHKLINE BEECHAM CORP42 citations95
US6323333B1Nov 27, 2001
Mouse EDG1
SMITHKLINE BEECHAM CORP6 citations73
US6344342B1Feb 5, 2002
Human G protein coupled lysophosphatidic acid receptor
SMITHKLINE BEECHAM CORP7 citations71
US6344542B1Feb 5, 2002
Human EDG3sb gene
SMITHKLINE BEECHAM CORP2 citations62
US6242572B1Jun 5, 2001
Human G protein coupled lysophosphatidic acid receptor
SMITHKLINE BEECHAM CORP4 citations60
US6180365B1Jan 30, 2001
Polynucleotide encoding a Mouse 7-transmembrane GPR43 receptor
SMITHKLINE BEECHAM CORP5 citations59
US6143521ANov 7, 2000
Human bombesin receptor subtype-3sb
SMITHKLINE BEECHAM CORP5 citations59
US6043052AMar 28, 2000
GPR 25 polynucleotides
SMITHKLINE BEECHAM CORP4 citations59
US6355452B1Mar 12, 2002
Human histamine H3 gene variant-2
SMITHKLINE BEECHAM CORP1 citations51
MEDIMMUNE LTD
4 patentsUS11634483B2Apr 25, 2023
Nucleic acids encoding anti-VEGF-A antibodies and uses thereof
MEDIMMUNE LTD0 citations58
US11566068B2Jan 31, 2023
Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses thereof
MEDIMMUNE LTD0 citations58
US10919958B2Feb 16, 2021
Anti-VEGF-A antibodies and uses thereof
MEDIMMUNE LTD0 citations58
US10836819B2Nov 17, 2020
Anti-VEGF-A and anti-ANG2 antibodies and uses thereof
MEDIMMUNE LTD0 citations48
BOSTON PHARMACEUTICALS INC
3 patentsUS10022443B2Jul 17, 2018
Antibodies specific for IL-21 and uses thereof
BOSTON PHARMACEUTICALS INC1 citations57
US11529415B2Dec 20, 2022
Antibodies specific for IL-21 and uses thereof
BOSTON PHARMACEUTICALS INC0 citations56
US10588969B2Mar 17, 2020
Antibodies specific for IL-21 and uses thereof
BOSTON PHARMACEUTICALS INC0 citations46